Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
复制标题
DOI:
10.1016/j.juro.2014.01.088
复制
发表时间:
2014-07
影响因子:
6.6
通讯作者:
Ostrovnaya, Irina
中科院分区:
文献类型:
--
作者:
Hakimi, A. Ari;Mano, Roy;Ciriello, Giovanni;Gonen, Mithat;Mikkilineni, Nina;Sfakianos, John P.;Kim, Philip H.;Motzer, Robert J.;Russo, Paul;Reuter, Victor E.;Hsieh, James J.;Ostrovnaya, Irina
Several recently reported recurrent genomic alterations in clear cell renal cell carcinoma (ccRCC) are linked to pathological and clinical outcomes. We determined if any of the recurrent cancer gene mutations or copy number alterations identified in the Cancer Genome Atlas (TCGA) ccRCC dataset could add to the predictive accuracy of the current prognostic models. 413 patients who underwent nephrectomy/partial nephrectomy with whole exome, copy number array analyses, and clinical variables were interrogated. Sixty-five recurrent genomic alterations were identified based on prevalence and combined into 35 alterations including 12 cancer gene mutations. The genomic markers were modeled using the elastic-net algorithm with preoperative variables (tumor size + age) and in the postoperative setting using the externally validated Mayo Clinic stage, size, grade, and necrosis (SSIGN) prognostic scoring system. These models were subjected to internal validation using bootstrap. The median follow up for survivors was 45 months. Several markers correlated with adverse cancer-specific survival (CSS) and time to recurrence (TTR) on univariate analysis. However, most lost significance when controlling for tumor size +/- age in the preoperative models or SSIGN score in the postoperative setting. The addition of multiple genomic markers selected by the elastic-net algorithm failed to substantially add to the predictive accuracy of any of the preoperative or postoperative models for CSS or TTR. While recurrent copy number alterations and cancer gene mutations are biologically significant, they do not appear to improve the predictive accuracy of existing clinical CSS or TTR models in ccRCC.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-12-3886
发表时间:
2013-06-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Hakimi AA;Ostrovnaya I;Reva B;Schultz N;Chen YB;Gonen M;Liu H;Takeda S;Voss MH;Tickoo SK;Reuter VE;Russo P;Cheng EH;Sander C;Motzer RJ;Hsieh JJ;ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators
通讯作者:
ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators
影响因子:
64.8
作者:
Varela, Ignacio;Tarpey, Patrick;Raine, Keiran;Huang, Dachuan;Ong, Choon Kiat;Stephens, Philip;Davies, Helen;Jones, David;Lin, Meng-Lay;Teague, Jon;Bignell, Graham;Butler, Adam;Cho, Juok;Dalgliesh, Gillian L.;Galappaththige, Danushka;Greenman, Chris;Hardy, Claire;Jia, Mingming;Latimer, Calli;Lau, King Wai;Marshall, John;McLaren, Stuart;Menzies, Andrew;Mudie, Laura;Stebbings, Lucy;Largaespada, David A.;Wessels, L. F. A.;Richard, Stephane;Kahnoski, Richard J.;Anema, John;Tuveson, David A.;Perez-Mancera, Pedro A.;Mustonen, Ville;Fischer, Andrej;Adams, David J.;Rust, Alistair;Chan-on, Waraporn;Subimerb, Chutima;Dykema, Karl;Furge, Kyle;Campbell, Peter J.;Teh, Bin Tean;Stratton, Michael R.;Futreal, P. Andrew
通讯作者:
Futreal, P. Andrew
影响因子:
6.6
作者:
Kattan, MW;Reuter, V;Russo, P
通讯作者:
Russo, P
影响因子:
7.5
作者:
Brunelli, Matteo;Eccher, Albino;Martignoni, Guido
通讯作者:
Martignoni, Guido
影响因子:
6.2
作者:
Tan, Min-Han;Li, Huihua;Cheng, Christopher
通讯作者:
Cheng, Christopher